Brendan Hannah - 05 Dec 2025 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Reporting relationship: CBO, COO & CCO
Issuer ticker: QNCX
Reported as of: 05 Dec 2025
Net transaction value: +$25,012
SEC form: 4
Accepted by SEC: 08 Dec 2025, 08:12:05 UTC
Prior SEC filing: 23 Jun 2025
Next SEC filing: 23 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Brendan Hannah

Key filing fact

Brendan Hannah filed Form 4 for Quince Therapeutics, Inc. (QNCX) on 08 Dec 2025.

Key facts

This page summarizes Brendan Hannah's Form 4 filing for Quince Therapeutics, Inc. (QNCX).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 08 Dec 2025, 08:12.

Change

Previous filing in this sequence was filed on 23 Jun 2025.
Current net transaction value: +$25,012.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001929422 Primary reporting owner

Hannah Brendan

Relationship: CBO, COO & CCO
Address: C/O QUINCE THERAPEUTICS, INC., 611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Signature: /s/ Brendan Hannah
Signature date: 06 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QNCX transaction

Common Shares

Options Exercise

Transaction value: $1,249
Shares: +2,271
Change %: +0.68%
Price: $0.5500
Shares after: 336,547
Date: 05 Dec 2025
Ownership: Direct

QNCX transaction

Common Shares

Options Exercise

Transaction value: $23,763
Shares: +25,280
Change %: +7.5%
Price: $0.9400
Shares after: 361,827
Date: 05 Dec 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QNCX transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -2,271
Change %: -4.8%
Price: $0.000000
Shares after: 45,168
Date: 05 Dec 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 2,271
Exercise price: $0.5500
Footnotes: F1

QNCX transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -25,280
Change %: -11%
Price: $0.000000
Shares after: 199,720
Date: 05 Dec 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 25,280
Exercise price: $0.9400
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents grant of 103,500 employee stock options on May 19, 2022, which vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.

Footnote F2

Represents grant of 225,000 employee stock options on February 2, 2023, which vest in equal monthly installments at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, with full vesting on the fourth annual anniversary of the vesting commencement date.